Table of Contents

company-logo

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

Ampio Pharmaceuticals Dividend Announcement

• Ampio Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Ampio Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Ampio Pharmaceuticals Dividend History

Ampio Pharmaceuticals Dividend Yield

Ampio Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ampio Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Ampio Pharmaceuticals Financial Ratios

P/E ratio-0.00
PEG ratio0.00
P/B ratio0.00
ROE-91.28%
Payout ratio0.00%
Current ratio2.36
Quick ratio2.36
Cash Ratio1.72

Ampio Pharmaceuticals Dividend FAQ

Does Ampio Pharmaceuticals stock pay dividends?
Ampio Pharmaceuticals does not currently pay dividends to its shareholders.
Has Ampio Pharmaceuticals ever paid a dividend?
No, Ampio Pharmaceuticals has no a history of paying dividends to its shareholders. Ampio Pharmaceuticals is not known for its dividend payments.
Why doesn't Ampio Pharmaceuticals pay dividends?
There are several potential reasons why Ampio Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ampio Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ampio Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ampio Pharmaceuticals a dividend aristocrat?
Ampio Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ampio Pharmaceuticals a dividend king?
Ampio Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ampio Pharmaceuticals a dividend stock?
No, Ampio Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ampio Pharmaceuticals stocks?
To buy Ampio Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ampio Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.